Diclofenac Sodium, a minuscule molecule drug, wields its prowess by targeting the COX enzyme as an inhibitor. It is employed in the management of a wide range of conditions, such as bursitis, cervicobrachial syndrome, low back pain, tendinopathy, cancer pain, and osteoarthritis. First approved on August 8th, 1973, it was developed by Novartis. This multi-faceted medication combats inflammation, pain, and fever by curtailing the production of prostaglandins. Patients can take Diclofenac Sodium in a plethora of forms, including oral tablets, topical gels, and injections. The drug is undoubtedly a valuable asset for managing pain and inflammation. However, like most drugs, it can have side effects such as stomach ulcers and heightened cardiovascular risks. Due to its potential adverse effects, patients should be closely monitored by healthcare professionals before and during administration. Therefore, the use of Diclofenac Sodium should be specifically tailored to each patient's needs. Click on the image below to begin the exploration journey of Diclofenac through the Synapse database!
You can search for the latest pharmaceutical information such as drugs, targets, patents, transactions, clinical results, etc. through the Synapse database. Come and experience it!